Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELL | P14151 | 1/20 | 0.67 |
| ▸ | SELP | P16109 | 1/20 | 0.67 |
| ▸ | CA1 | P00915 | 5/20 | 0.52 |
| ▸ | CA2 | P00918 | 5/20 | 0.52 |
| ▸ | CA12 | O43570 | 4/20 | 0.52 |
| ▸ | CA7 | P43166 | 4/20 | 0.52 |
| ▸ | CA9 | Q16790 | 4/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KDR | P35968 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | PDE4A | P27815 | 1/20 | 0.47 |
| ▸ | BLVRB | P30043 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | LDHA | P00338 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29402788 | 1.00 | SELL (0.67) | SELLSELPCA1CA2CA12 | |
| Terephthalic Acid SCHEMBL9741357 | 0.92 | SELL (0.57) | SELLSELPCA1CA2CA12 | |
| SCHEMBL2115924 | 0.85 | SELL (0.58) | SELLSELPCA1CA2CA12 | |
| SCHEMBL7095311 | 0.85 | SELL (0.59) | SELLSELPCA1CA2CA12 | |
| SCHEMBL22939098 | 0.84 | KMT2A (0.59) | SELLSELPCA1CA2CA12 | |
| SCHEMBL1401756 | 0.84 | SELL (0.48) | SELLSELPCA1CA2CA12 | |
| SCHEMBL27968192 | 0.83 | SELL (0.56) | SELLSELPCA1CA2CA12 | |
| SCHEMBL514758 | 0.83 | SELL (0.56) | SELLSELPCA1CA2CA12 | |
| SCHEMBL27968303 | 0.83 | SELL (0.56) | SELLSELPCA1CA2CA12 | |
| SCHEMBL27968358 | 0.83 | SELL (0.56) | SELLSELPCA1CA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 624 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260084134-A1 | STORAGE AND DELIVERY OF GASEOUS CHEMICAL REACTANTS IN CHEMICAL PROCESSES USING METAL-ORGANIC FRAMEWORKS | UNIV CORNELL (US) | 2026-03-26 | — | — | US | claimed |
| CN-118530172-A | Pd for selectively recognizing 1, 4-benzoquinone2L4Metal organic molecular cage and preparation method thereof | 四川大学 | 2024-08-23 | — | — | CN | claimed |
| CN-112955498-B | Polybenzimidazole (PBI) membrane for redox flow battery | 南卡罗来纳大学 | 2024-05-10 | — | — | CN | claimed |
| WO-2023205455-A2 | STORAGE AND DELIVERY OF GASEOUS CHEMICAL REACTANTS IN CHEMICAL PROCESSES USING METAL-ORGANIC FRAMEWORKS | CORNELL UNIVERSITY (US) | 2023-10-26 | — | — | WO | claimed |
| US-11482721-B2 | Low permeability polybenzimidazole (PBI) gel membranes for redox flow batteries | UNIVERSITY OF SOUTH CAROLINA (US) | 2022-10-25 | — | — | US | claimed |
| US-11302948-B2 | Polybenzimidazole (PBI) membranes for redox flow batteries | UNIVERSITY OF SOUTH CAROLINA (US) | 2022-04-12 | — | — | US | claimed |
| EP-3850698-A2 | LOW PERMEABILITY POLYBENZIMIDAZOLE (PBI) MEMBRANES FOR REDOX FLOW BATTERIES | University of South Carolina (US) | 2021-07-21 | — | — | EP | claimed |
| EP-3850697-A1 | POLYBENZIMIDAZOLE (PBI) MEMBRANES FOR REDOX FLOW BATTERIES | University of South Carolina (US) | 2021-07-21 | — | — | EP | claimed |
| CN-112955498-A | Polybenzimidazole (PBI) membranes for redox flow batteries | 南卡罗来纳大学 | 2021-06-11 | — | — | CN | claimed |
| CN-112956056-A | Low permeability Polybenzimidazole (PBI) membranes for redox flow batteries | 南卡罗来纳大学 | 2021-06-11 | — | — | CN | claimed |
| US-20060261307-A1 | Water Activated Organic Scavenger | M&G USA CORPORATION | 2006-11-23 | — | — | US | claimed |
| US-20060210881-A1 | Proton-conducting membrane and use thereof | BASF FUEL CELL RESEARCH GMBH (DE) | 2006-09-21 | — | — | US | claimed |
| EP-1652259-A2 | PROTON-CONDUCTING MEMBRANE AND USE THEREOF | Pemeas GmbH (DE) | 2006-05-03 | — | — | EP | claimed |
| CN-1689186-A | Proton conducting membrane and application thereof | PEMEAS GMBH (DE) | 2005-10-26 | — | — | CN | claimed |
| CN-1682400-A | Proton-conducting polymer membrane comprising polymers containing sulfonic acid groups and use thereof in fuel cells | PEMEAS GMBH (DE) | 2005-10-12 | — | — | CN | claimed |
| WO-2005011039-A2 | PROTON-CONDUCTING MEMBRANE AND USE THEREOF | PEMEAS GMBH (DE) | 2005-02-03 | — | — | WO | claimed |
| EP-1200522-B1 | POLYESTER-POLYAMIDE BLENDS WITH REDUCED GAS PERMEABILITY AND LOW HAZE | EASTMAN CHEM CO (US) | 2004-05-06 | — | — | EP | claimed |
| US-6444283-B1 | CONTAINERS, PACKAGES FOR FOOD, DRUG, COSMETICS | EASTMAN CHEMICAL COMPANY | 2002-09-03 | — | — | US | claimed |
| EP-1200522-A1 | POLYESTER-POLYAMIDE BLENDS WITH REDUCED GAS PERMEABILITY AND LOW HAZE | EASTMAN CHEMICAL COMPANY (US) | 2002-05-02 | — | — | EP | claimed |
| WO-2001009245-A1 | POLYESTER-POLYAMIDE BLENDS WITH REDUCED GAS PERMEABILITY AND LOW HAZE | EASTMAN CHEMICAL COMPANY (US) | 2001-02-08 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260084134-A1 | STORAGE AND DELIVERY OF GASEOUS CHEMICAL REACTANTS IN CHEMICAL PROCESSES USING METAL-ORGANIC FRAMEWORKS | ME3, ME2, SLC25A11 | SELL 2797/4885SELP 3021/4885CA1 68/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.